Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: Association between invasive cancer and ipsilateral increased vascularity

Radiology

Volumn 235, Issue 3, 2005, Pages 791-797

  Sardanelli, Francesco ^a   Iozzelli, Andrea ^a   Fausto, Alfonso ^a   Carriero, Alessandro ^b   Kirchin, Miles A ^c  

^a San Donato Milanese   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c Worldwide Medical Affairs   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOBENATE DIMEGLUMINE; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BREAST CARCINOMA; BREAST TUMOR; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; FEMALE; HISTOPATHOLOGY; HUMAN; INFORMED CONSENT; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARALLEL DESIGN; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR VASCULARIZATION;

ADULT; AGED; BREAST; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD;

EID: 18844367490     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2353040733     Document Type: Article

References (35)

1. Sardanelli F, Iozzelli A, Fausto A. MR imaging of the breast: indications, established technique and new directions. Eur Radiol 2003; 13(suppl 3):N28-N36.
2. Orel SG, Schnall MD, Powell CM, et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 1995; 196:115-122.
3. Boné B, Aspelin P, Bronge L, Isberg B, Perbeck L, Veress B. Sensitivity and specificity of MR mammography with histopathological correlation in 250 breasts. Acta Radiol 1996; 37: 208-213.
4. Heywang-Kobrunner SH, Viehweg P, Heinig A, Küchler C. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol 1997; 24:94-108.
5. Del Maschio A, Panizza P. Breast MR: state of the art. Eur J Radiol 1998; 27(suppl 2):S250-S253.
6. Fischer U, Westerhof JP, Brinck U, Korabiowska M, Schauer A, Grabbe E. Ductal carcinoma in situ in dynamic MR-mammography at 1.5 T. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1996; 164:290-294.
7. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999; 213:881-888.
8. Malur S, Wurdinger S, Moritz A, Michels W, Schneider A. Comparison of written reports of mammography, sonography and magnetic resonance mammography for preoperative evaluation of breast lesions, with special emphasis on magnetic resonance mammography. Breast Cancer Res 2001; 3:55-60.
9. Nunes LW, Schnall MD, Orel SG, et al. Breast MR imaging: interpretation model. Radiology 1997; 202:833-841.
10. Heywang SH, Hahn D, Schmidt H, et al. MR imaging of the breast using gadolinium-DTPA. J Comput Assist Tomogr 1986; 10: 199-204.
11. Sardanelli F, Iozzelli A, Fausto A. Contrast agents and temporal resolution in breast MR imaging. J Exp Clin Cancer Res 2002; 21(suppl):69-75.
12. Cavagna FM, Maggioni F, Castelli PM, et al. Gadolinium chelates with weak binding to serum proteins: a new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 1997; 32:780-796.
13. Kirchin MA, Pirovano G, Spinazzi A. Gadobenate dimeglumine (Gd-BOPTA): an overview. Invest Radiol 1998; 33:798-809.
14. Spinazzi A, Lorusso V, Pirovano G, Kirchin M. Safety, tolerance, biodistribution and MR imaging enhancement of the liver with gadobenate dimeglumine. Acad Radiol 1999; 6:282-291.
15. Knopp MV, Runge VM, Essig M, et al. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology 2004; 230:55-64.
16. Knopp MV, Schoenberg SO, Rehm C, et al. Assessment of gadobenate dimeglumine (Gd-BOPTA) for MR angiography: phase I studies. Invest Radiol 2002; 37:706-715.
17. Knopp MV, Giesel FL, von Tengg-Kobligk H, et al. Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine. J Magn Reson Imaging 2003; 17:694-702.
18. Prokop M, Schneider G, Vanzulli A, et al. Contrast-enhanced MR angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology 2005; 234:399-408.
19. Wyttenbach R, Gianella S, Alerci M, Braghetti A, Cozzi L, Gallino A. Prospective blinded evaluation of Gd-DOTA- versus Gd-BOPTA-enhanced peripheral MR angiography, as compared with digital subtraction angiography. Radiology 2003; 227:261-269.
20. Wilson CB, Lammertsma AA, McKenzie CG, Sikora K, Jones T. Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: a rapid and noninvasive dynamic method. Cancer Res 1992; 52:1592-1597.
21. Hulka CA, Smith BL, Sgroi DC, et al. Benign and malignant breast lesions: differentiation with echo-planar MR imaging. Radiology 1995; 197:33-38.
22. Hulka CA, Edmister WB, Smith BL, et al. Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. Radiology 1997; 205:837-842.
23. Sardanelli F, Rescinito G, Giordano GD, Calabrese M, Parodi RC. MR dynamic enhancement of breast lesions: high temporal resolution during the first-minute versus eight-minute study. J Comput Assist Tomogr 2000; 24:724-731.
24. Kvistad KA, Rydland J, Vainio J, et al. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging. Radiology 2000; 216:545-553.
25. Alamo L, Fischer U. Contrast-enhanced color Doppler ultrasound characteristics in hypervascular breast tumors: comparison with MRl. Eur Radiol 2001; 11:970-977.
26. Seifalian AM, Chaloupka K, Parbhoo SP. Laser Doppler perfusion imaging: a new technique for measuring breast skin blood flow. Int J Microcirc Clin Exp 1995; 15:125-130.
27. Mahfouz AE, Sherif H, Saad A, et al. Gadolinium-enhanced MR angiography of the breast: is breast cancer associated with ipsilateral higher vascularity? Eur Radiol 2001; 11:965-969.
28. Carriero A, Di Credico A, Mansour M, Bonomo L. Maximum intensity projection analysis in magnetic resonance of the breast. J Exp Clin Cancer Res 2002; 21(suppl):77-81.
29. Knopp MV, Bourne MW, Sardanelli F, et al. Gadobenate dimeglumine in contrast-enhanced magnetic resonance imaging of the breast: a dose response analysis and comparison with gadopentetate dimeglumine. AJR Am J Roentgenol 2003; 181:663-676.
30. Del Maschio A, De Gaspari A, Panizza P. Magnetic Resonance in breast imaging. Radiol Med (Torino) 2002; 104:253-261.
31. Cancer statistics in developing countries: report on a WHO meeting, Nagoya, Japan, August 18-22, 1981. World Health Stat Q 1983; 36:213-217.
32. Newcombe RG, Altman DG. Proportions and their differences. In: Altman DG, Machin D, Bryant TN, Gardner MJ, eds. Statistics with confidence: confidence intervals and statistical guidelines. 2nd ed. London, England: BJM Book-BMA House, 2000; 46-58.
33. Cristofanilli M, Charnsangavej C, Hortobagyi GN. Angiogenesis modulation in cancer research: novel clinical approaches. Nat Rev Drug Discov 2002; 1:415-426.
34. Esteva FJ, Sahin AA, Cristofanilli M, Arun B, Hortobagyi GN. Molecular prognostic factors for breast cancer metastasis and survival. Semin Radiat Oncol 2002; 12:319-328.
35. Kuhl CK. MRI of breast tumors. Eur Radiol 2000; 10:46-58.